Comparison of PSORI-CM01 granules and Yinxieling tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial | Zendy

Danni Yao | Zendy; Chuanjian Lu | Zendy; Zehuai Wen | Zendy; Yuhong Yan | Zendy; Liming Lu | Zendy; Huimei Wu | Zendy; Ziyang He | Zendy; Hao Deng | Zendy; Jingwen Deng | Zendy

Open Access

Comparison of PSORI-CM01 granules and Yinxieling tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial

Author(s) -

Danni Yao,

Chuanjian Lu,

Zehuai Wen,

Yuhong Yan,

Liming Lu,

Huimei Wu,

Ziyang He,

Hao Deng,

Jingwen Deng

Publication year - 2021

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-2575

Subject(s) - medicine , double blinded , plaque psoriasis , psoriasis , randomized controlled trial , dermatology , pilot trial , placebo , alternative medicine , pathology

To compare the efficacy and safety of PSORI-CM01 granules with Yinxieling tablets in patients with chronic plaque psoriasis (CPP), we plan to conduct a multicentre, randomized, double-blinded, double-dummy, controlled trial. This pilot study was conducted to determine the feasibility and the potential of the protocol for the full-scale randomized controlled trial (RCT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research